Back to Search Start Over

Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study

Authors :
Neurociencias
Neurozientziak
Wang, Youjin
Best, Ana
Fernández Torrón, Roberto
Alsaggaf, Rotana
García Puga, Mikel
Dagnall, Casey L.
Hicks, Belynda
Thompson, Mone’t
Matheu Fernández, Ander
Zulaica Ijurco, Miren
Greene, Mark H.
López de Munain Arregui, Adolfo José
Gadalla, Shahinaz M.
Neurociencias
Neurozientziak
Wang, Youjin
Best, Ana
Fernández Torrón, Roberto
Alsaggaf, Rotana
García Puga, Mikel
Dagnall, Casey L.
Hicks, Belynda
Thompson, Mone’t
Matheu Fernández, Ander
Zulaica Ijurco, Miren
Greene, Mark H.
López de Munain Arregui, Adolfo José
Gadalla, Shahinaz M.
Publication Year :
2019

Abstract

Myotonic dystrophy type I (DM1) is an autosomal dominant disease of which clinical manifestations resemble premature aging. We evaluated the contribution of telomere length in pathogenesis in 361 DM1 patients (12 with serial measurements) and 223 unaffected relative controls using qPCR assay. While no differences in baseline leukocyte relative telomere length (RTL) was noted, the data suggested an accelerated RTL attrition in DM1 (discovery cohort: T/S change/year = -0.013 in DM1 vs. -0.005 in controls, P = 0.04); similar trend was noted in validation cohort. Further investigations are needed to examine the role of TL in the pathophysiology of DM1.

Details

Database :
OAIster
Notes :
The study was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health., English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1364713369
Document Type :
Electronic Resource